If One Parent Has Sickle Cell Trait Will the Child Have It?

Whether a child inherits sickle cell trait depends almost entirely on what the other parent carries. If one parent has sickle cell trait and the other has completely normal hemoglobin, each pregnancy carries roughly a one-in-two chance the child will inherit the trait and a one-in-two chance the child will not. Sickle cell disease is not on the table in that pairing. The picture changes sharply when the other parent also carries an abnormal hemoglobin gene, and many couples don’t discover that until after a baby is born and screened.

What Sickle Cell Trait Actually Means

Sickle cell trait is the carrier state: a person inherits one gene for normal hemoglobin from one parent and one gene for sickle hemoglobin from the other. People with the trait produce both normal hemoglobin (HbA) and sickle hemoglobin (HbS), with normal hemoglobin making up the majority and HbS accounting for roughly 30 to 40 percent of total hemoglobin. Because the normal hemoglobin dominates, carriers generally don’t experience the painful episodes or organ damage associated with sickle cell disease and are typically asymptomatic.¹

Sickle cell disease is a different situation. It occurs when a person inherits a sickle hemoglobin gene from one parent and either another sickle gene or a different abnormal hemoglobin gene from the other parent. The combinations that produce disease include inheriting two sickle genes (sickle cell anemia), inheriting sickle hemoglobin alongside hemoglobin C, hemoglobin D Punjab, hemoglobin E, or a beta-thalassemia gene, among others. Each of these pairings results in a form of sickle cell disease with varying severity. The underlying cause in all cases traces to a single change in the beta-globin gene, where one amino acid is swapped for another, producing hemoglobin that can polymerize and distort red blood cells under low-oxygen conditions.²

When Only One Parent Has the Trait

If one parent has sickle cell trait (carries one normal gene and one sickle gene) and the other parent has two normal hemoglobin genes, there are only two outcomes for each pregnancy. The child either inherits the sickle gene and becomes a trait carrier like the affected parent, or the child inherits the normal gene and has no connection to sickle cell at all. The odds split evenly, roughly 50-50 per pregnancy. No combination of these two parents’ genes can produce sickle cell disease, because the child can never receive more than one copy of the sickle gene.

This is the scenario many people are asking about, and the reassuring part is straightforward: your child might carry the trait, but they won’t have sickle cell disease from this pairing alone. Each pregnancy is an independent event, though, so having one child with the trait doesn’t mean the next one will or won’t.

When Both Parents Carry Sickle Cell Trait

The stakes change considerably when both parents are trait carriers. In this pairing, each pregnancy has roughly a one-in-four chance of producing a child with sickle cell anemia, a one-in-two chance of producing a trait carrier, and a one-in-four chance of producing a child with no sickle gene at all. This is where genetic counseling becomes genuinely important, because many couples don’t learn about both partners’ carrier status until after a child is diagnosed through newborn screening.

Research on genetic counseling after newborn screening found that only about 21 percent of parents whose child was identified as having sickle cell or hemoglobin C trait had discussed sickle cell with their partner before or during the pregnancy. After receiving counseling, 81 percent reported having that conversation.³ The gap between those numbers suggests many couples are blindsided by this information, which is avoidable with earlier testing.

The Other Parent’s Hemoglobin Matters More Than You Think

Sickle hemoglobin is not the only variant floating around in the population. Hemoglobin C, hemoglobin D Punjab, hemoglobin E, and beta-thalassemia genes are all relatively common in certain populations. If one parent has sickle cell trait and the other carries one of these other variants, their children can end up with a form of sickle cell disease even though neither parent has the disease themselves. Sickle-hemoglobin C disease and sickle-beta-thalassemia are real clinical conditions that cause symptoms ranging from mild to severe.¹

This is why knowing your own trait status is only half the picture. The other parent’s hemoglobin genotype determines whether sickle cell disease is even possible. A simple blood test, typically hemoglobin electrophoresis or high-performance liquid chromatography, can identify the vast majority of hemoglobin variants.⁴ If you know you carry sickle cell trait and are thinking about having children, getting your partner tested is the single most useful step you can take.

Newborn Screening and How Carriers Are Found

In the United States, all 50 states include sickle cell on their newborn screening panels. A small blood sample is taken from the baby’s heel shortly after birth, and the sample is sent to the state’s public health laboratory. The timing of results varies by state, from a couple of days to about a week. States also vary widely in how many new cases they detect per year, with some identifying around 60 new cases of sickle cell disease annually and others closer to 200.⁵

Newborn screening catches both sickle cell disease and sickle cell trait, which means many parents first learn their child is a carrier through this process. If you weren’t tested before pregnancy, this is often the moment the conversation starts. The screening itself is highly reliable, but the follow-up infrastructure, including how quickly families are contacted, whether genetic counseling is offered, and how well the information is communicated, differs significantly from state to state.

Is Sickle Cell Trait Truly Harmless?

For decades, the standard medical message was that sickle cell trait is completely benign. That’s mostly true, but the picture has gotten more nuanced. The vast majority of trait carriers go through life without any symptoms related to their hemoglobin. However, under specific extreme conditions, the small amount of HbS in a carrier’s blood can cause problems.

The most serious documented risk involves intense physical exertion at high altitudes, in extreme heat, or during severe dehydration. Sickle cell trait has been identified as the leading cause of sudden death among young African American military recruits during basic training and has been implicated in the deaths of college football players during intense conditioning.⁶ These events are rare, but they’ve prompted real changes in how the military and athletic organizations handle training for carriers.

An expert panel convened by the American College of Sports Medicine developed recommendations specifically aimed at reducing these risks for athletes and military personnel with the trait, focusing on gradual conditioning, hydration, rest periods, and rapid recognition of exertional collapse.⁷ If your child turns out to carry the trait, this is worth knowing as they get into competitive sports, but it is not a reason to keep them from being active.

There’s also emerging evidence that sickle cell trait can affect kidney function over time. Research has found that trait carriers without alpha-thalassemia co-inheritance had roughly 2.6 times the odds of chronic kidney disease compared to non-carriers, though co-inheriting an alpha-thalassemia deletion appeared to significantly reduce that risk.⁸ The interaction between alpha-thalassemia genes and the sickle gene is a good example of why individual trait carriers can have quite different clinical experiences depending on what other genetic variants they happen to carry.

Why the Sickle Gene Is So Common in the First Place

A gene that can cause severe disease when inherited in two copies would normally be weeded out over time. The reason the sickle gene remains so prevalent, particularly in populations with roots in sub-Saharan Africa, the Mediterranean, the Middle East, and parts of India, is that carrying one copy provides a genuine survival advantage in areas where malaria is endemic.

Sickle cell trait confers partial protection against severe malaria caused by Plasmodium falciparum. One study in children found that trait carriers had almost 40 percent protection against mild clinical malaria overall, with the level of protection varying by age: it was about 20 percent in early childhood, climbed to almost 60 percent during the first decade of life, and then settled around 30 percent afterward.⁹ This age pattern suggests the protection involves not just the physical properties of sickle hemoglobin but also the immune system learning to fight the parasite more effectively.

The mechanism works in part because when malaria parasites infect red blood cells carrying HbS, those cells are more likely to sickle under the low-oxygen conditions found in small blood vessels. The parasites essentially get trapped: they stall in the middle of their growth cycle before they can replicate, which limits how fast the infection can spread through the body.¹⁰ Additional research has identified further immune-related mechanisms, including enhanced tolerance to malaria-related inflammation and even the transfer of certain molecules from the host cell into the parasite that interfere with its survival.¹¹

Mapping of the sickle gene’s global distribution lines up well with historical malaria zones, particularly in Africa, providing geographic evidence for this evolutionary trade-off.¹² The relationship is less clear in the Americas and Asia, where population migrations have redistributed the gene beyond its original malaria-driven range.

How Alpha-Thalassemia Changes the Picture

Alpha-thalassemia is another inherited hemoglobin condition, and it’s common in many of the same populations where sickle cell trait is prevalent. When someone inherits both sickle cell trait and alpha-thalassemia deletions, the two conditions interact in ways that can modify how the sickle gene expresses itself.

In children who carry both sickle cell trait and two copies of the alpha-thalassemia deletion, researchers found that the usual drop in hemoglobin levels and the changes in red blood cell size associated with alpha-thalassemia were less pronounced than they would be in someone without the sickle gene.¹³ In other words, the two conditions partially offset each other’s effects on routine blood counts. As noted earlier, co-inheritance of alpha-thalassemia deletions also appears to reduce the kidney disease risk associated with sickle cell trait alone. This kind of gene-gene interaction is one reason two people who both carry sickle cell trait can have noticeably different health profiles.

Family Planning Options When Both Partners Carry a Variant

If both partners carry sickle cell trait, or if one carries the trait and the other carries a different hemoglobin variant, the question shifts from “will my child have the trait” to “could my child have sickle cell disease?” Several reproductive options exist for couples in this situation.

Preimplantation genetic testing (PGT-M) is an option that pairs with in vitro fertilization. Embryos are created through IVF and then tested for the sickle gene before being transferred. A cost-effectiveness analysis found that IVF with PGT-M was the optimal strategy in over 93 percent of modeled scenarios when compared against standard-of-care treatment for a child born with sickle cell disease, yielding both cost savings and additional years of healthy life.¹⁴ Real-world results from a single center found that roughly a third of couples who pursued PGT-M achieved at least one live birth following embryo transfer.¹⁵ The process is expensive and physically demanding, but it offers the ability to select embryos unaffected by disease before pregnancy begins.

Prenatal diagnosis is another pathway. Traditional methods use chorionic villus sampling or amniocentesis to obtain fetal cells for genetic testing. Newer non-invasive prenatal testing (NIPT) approaches, which analyze fetal DNA circulating in the mother’s blood, are being developed for sickle cell and may allow detection as early as five to six weeks into pregnancy with improved safety.¹⁶ Research has also explored reprogramming fetal cells obtained during prenatal diagnosis into stem cells that could theoretically be used for future therapeutic purposes, though this remains experimental.¹⁷

How People Actually Navigate Partner Testing

The genetics are one thing; the human side is another. Research interviewing adults with sickle cell disease about their family-building experiences found that all participants said they would ask any future partner about their sickle cell trait status, and most had already done so with at least one partner. But the timing varied enormously. Some asked early in a relationship to decide whether to keep dating. Others waited until the relationship became serious or until they were already pregnant.¹⁸

The range of responses to a partner’s carrier status was just as wide. Some said they would proceed with having children regardless but wanted to be prepared for the possibility of a child with sickle cell disease. Others said they would choose a different partner or forgo biological children entirely, often citing their own painful experiences with the disease. One participant captured the tension succinctly by saying they didn’t feel people with sickle cell don’t deserve to be here. There’s no single right answer to these decisions, but having the information early enough to make a deliberate choice is something almost everyone in these studies valued.

If you carry sickle cell trait and want to understand what that means for your future children, the first step is getting your partner tested. A simple hemoglobin analysis can identify whether they carry the sickle gene, another hemoglobin variant, or normal hemoglobin. From there, genetic counseling can walk you through the specific probabilities and options for your particular pairing. Many people find that the anxiety around these questions drops considerably once they have concrete information to work with rather than vague worry.